SUNZEN

Quarterly rpt on consolidated results for the financial period ended 31 Dec 2022

SUNZEN BIOTECH BERHAD

Financial Year End 31 Dec 2022
Quarter 4 Qtr
Quarterly report for the financial period ended 31 Dec 2022
The figures have not been audited

Attachments

QUARTERLY REPORT Q4 2022.pdf
339.8 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2022

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2022
31 Dec 2021
31 Dec 2022
31 Dec 2021
$$'000
$$'000
$$'000
$$'000
1 Revenue
17,036
28,995
97,103
90,479
2 Profit/(loss) before tax
1,637
2,095
7,348
3,705
3 Profit/(loss) for the period
1,188
1,157
4,653
1,938
4 Profit/(loss) attributable to ordinary equity holders of the parent
1,141
667
3,636
680
5 Basic earnings/(loss) per share (Subunit)
0.16
0.12
0.51
0.12
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.1700
0.1700

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name SUNZEN BIOTECH BERHAD
Stock Name SUNZEN
Date Announced 23 Feb 2023
Category Financial Results
Reference Number FRA-16022023-00009